{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:53:22Z","timestamp":1781571202620,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100024728","name":"Instytut Immunologii i Terapii Do\u015bwiadczalnej, im. Ludwika Hirszfelda Polskiej Akademii Nauk","doi-asserted-by":"publisher","award":["14\/2018"],"award-info":[{"award-number":["14\/2018"]}],"id":[{"id":"10.13039\/501100024728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.humimm.2024.110797","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T14:43:41Z","timestamp":1712328221000},"page":"110797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Polymorphisms in the CD6-ALCAM axis may modulate psoriasis risk and outcomes"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2710-2301","authenticated-orcid":false,"given":"Marta","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2428-0927","authenticated-orcid":false,"given":"Maciej","family":"Sobczy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1919-2298","authenticated-orcid":false,"given":"Andrzej","family":"Wi\u015bniewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0141ukasz","family":"Matusiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9224-8921","authenticated-orcid":false,"given":"Piotr","family":"Ku\u015bnierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Jasek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9997","key":"10.1016\/j.humimm.2024.110797_b0005","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0010","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ajhg.2012.03.012","article-title":"PSORS2 is due to mutations in CARD14","volume":"90","author":"Jordan","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.humimm.2024.110797_b0015","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jid.2016.11.007","article-title":"Recent highlights in psoriasis Research","volume":"137","author":"Hwang","year":"2017","journal-title":"J. Invest Dermatol"},{"issue":"12","key":"10.1016\/j.humimm.2024.110797_b0020","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ng.2467","article-title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","volume":"44","author":"Tsoi","year":"2012","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.humimm.2024.110797_b0025","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.3390\/ijms18122650","article-title":"The immunogenetics of psoriasis and implications for drug repositioning","volume":"18","author":"Xu","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2024.110797_b0030","doi-asserted-by":"crossref","first-page":"adv00030","DOI":"10.2340\/00015555-3384","article-title":"Psoriasis and genetics","volume":"100","author":"Dand","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"10","key":"10.1016\/j.humimm.2024.110797_b0035","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/cmi.2017.119","article-title":"Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis","volume":"15","author":"Consuegra-Fernandez","year":"2018","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"10.1016\/j.humimm.2024.110797_b0040","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1073\/pnas.1615253114","article-title":"CD6 as a potential target for treating multiple sclerosis","volume":"114","author":"Li","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0045","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145662","article-title":"CD6 is a target for cancer immunotherapy","volume":"6","author":"Ruth","year":"2021","journal-title":"JCI Insight"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0050","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.autrev.2017.12.004","article-title":"Clinical and experimental evidence for targeting CD6 in immune-based disorders","volume":"17","author":"Consuegra-Fernandez","year":"2018","journal-title":"Autoimmun Rev."},{"issue":"1\u20132","key":"10.1016\/j.humimm.2024.110797_b0055","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jneuroim.2013.02.015","article-title":"ALCAM\u2013novel multiple sclerosis locus interfering with HLA-DRB1*1501","volume":"258","author":"Wagner","year":"2013","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.humimm.2024.110797_b0060","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jneuroim.2014.08.621","article-title":"ALCAM and CD6 - multiple sclerosis risk factors","volume":"276","author":"Wagner","year":"2014","journal-title":"J Neuroimmunol"},{"issue":"3","key":"10.1016\/j.humimm.2024.110797_b0065","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0002-9440(10)64943-7","article-title":"Activated leukocyte cell adhesion molecule\/CD166, a marker of tumor progression in primary malignant melanoma of the skin","volume":"156","author":"van Kempen","year":"2000","journal-title":"Am J. Pathol"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0070","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J. Am Acad Dermatol"},{"issue":"7414","key":"10.1016\/j.humimm.2024.110797_b0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature11247","article-title":"An integrated encyclopedia of DNA elements in the human genome","volume":"489","author":"Strange","year":"2012","journal-title":"Nature"},{"issue":"D1","key":"10.1016\/j.humimm.2024.110797_b0080","doi-asserted-by":"crossref","first-page":"D794","DOI":"10.1093\/nar\/gkx1081","article-title":"The Encyclopedia of DNA elements (ENCODE): data portal update","volume":"46","author":"Davis","year":"2018","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.humimm.2024.110797_b0085","first-page":"D756","article-title":"UCSC genome browser enters 20th year","volume":"48","author":"Lee","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.humimm.2024.110797_b0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1101\/gr.229102","article-title":"The human genome browser at UCSC","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res."},{"key":"10.1016\/j.humimm.2024.110797_b0095","doi-asserted-by":"crossref","first-page":"D56","DOI":"10.1093\/nar\/gks1172","article-title":"ENCODE data in the UCSC genome browser: year 5 update","volume":"41","author":"Rosenbloom","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2024.110797_b0100","doi-asserted-by":"crossref","first-page":"D930","DOI":"10.1093\/nar\/gkr917","article-title":"HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants","volume":"40","author":"Ward","year":"2012","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.humimm.2024.110797_b0105","doi-asserted-by":"crossref","first-page":"D877","DOI":"10.1093\/nar\/gkv1340","article-title":"HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease","volume":"44","author":"Ward","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2024.110797_b0110","doi-asserted-by":"crossref","first-page":"W600","DOI":"10.1093\/nar\/gkp290","article-title":"SNPinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies","volume":"37","author":"Xu","year":"2009","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.humimm.2024.110797_b0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.humimm.2017.11.010","article-title":"The association of ERAP1 and ERAP2 single nucleotide polymorphisms and their haplotypes with psoriasis vulgaris is dependent on the presence or absence of the HLA-C*06:02 allele and age at disease onset","volume":"79","author":"Wisniewski","year":"2018","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.humimm.2024.110797_b0120","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/genetics\/149.4.2079","article-title":"A bayesian characterization of hardy-weinberg disequilibrium","volume":"149","author":"Shoemaker","year":"1998","journal-title":"Genetics"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0125","first-page":"921","article-title":"Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population","volume":"12","author":"Excoffier","year":"1995","journal-title":"Mol. Biol. Evol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0130","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1297-9686-35-6-513","article-title":"Linkage disequilibrium fine mapping of quantitative trait loci: a simulation study","volume":"35","author":"Abdallah","year":"2003","journal-title":"Genet Sel Evol."},{"key":"10.1016\/j.humimm.2024.110797_b0135","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1080\/01621459.1993.10476408","article-title":"Alternatives to the median absolute deviation","volume":"88","author":"Rousseeuw","year":"1993","journal-title":"JASA"},{"issue":"11","key":"10.1016\/j.humimm.2024.110797_b0140","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.3390\/ijms18112427","article-title":"Treatment approaches to moderate to severe psoriasis","volume":"18","author":"Gisondi","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.humimm.2024.110797_b0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.disamonth.2018.06.001","article-title":"Biologics for the primary care physician: review and treatment of psoriasis","volume":"65","author":"Schadler","year":"2019","journal-title":"Dis Mon"},{"issue":"9","key":"10.1016\/j.humimm.2024.110797_b0150","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.autrev.2017.07.011","article-title":"Autoimmune aspects of psoriasis: heritability and autoantigens","volume":"16","author":"Prinz","year":"2017","journal-title":"Autoimmun Rev."},{"issue":"10","key":"10.1016\/j.humimm.2024.110797_b0155","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.tips.2014.07.006","article-title":"Targeting Th17 cells in autoimmune diseases","volume":"35","author":"Yang","year":"2014","journal-title":"Trends Pharmacol Sci."},{"issue":"11","key":"10.1016\/j.humimm.2024.110797_b0160","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1093\/hmg\/ddq101","article-title":"CIITA variation in the presence of HLA-DRB1*1501 increases risk for multiple sclerosis","volume":"19","author":"Bronson","year":"2010","journal-title":"Hum Mol. Genet"},{"key":"10.1016\/j.humimm.2024.110797_b0165","doi-asserted-by":"crossref","unstructured":"The ENCODE Project Consortium, Genetic Analysis of Psoriasis, C., et al., A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1, Nat Genet 42 (11) (2010) 985\u201390.","DOI":"10.1038\/ng.694"},{"issue":"1\u20132","key":"10.1016\/j.humimm.2024.110797_b0170","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jneuroim.2010.03.020","article-title":"Validation of the CD6 and TNFRSF1A loci as risk factors for multiple sclerosis in Spain","volume":"223","author":"Swaminathan","year":"2010","journal-title":"J. Neuroimmunol"},{"issue":"4","key":"10.1016\/j.humimm.2024.110797_b0175","doi-asserted-by":"crossref","first-page":"491","DOI":"10.4103\/0972-2327.192384","article-title":"CD6 gene polymorphism rs17824933 is associated with multiple sclerosis in indian population","volume":"19","author":"D'Cunha","year":"2016","journal-title":"Ann Indian Acad Neurol"},{"issue":"7","key":"10.1016\/j.humimm.2024.110797_b0180","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/ng.401","article-title":"Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci","volume":"41","author":"De Jager","year":"2009","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.humimm.2024.110797_b0185","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.4049\/jimmunol.1100626","article-title":"The CD6 multiple sclerosis susceptibility allele is associated with alterations in CD4+ T cell proliferation","volume":"187","author":"Kofler","year":"2011","journal-title":"J. Immunol"},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196635","article-title":"A catalog of potential putative functional variants in psoriasis genome-wide association regions","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.humimm.2024.110797_b0195","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/s10165-012-0706-x","article-title":"IKZF1: a critical role in the pathogenesis of systemic lupus erythematosus?","volume":"23","author":"Hu","year":"2013","journal-title":"Mod Rheumatol"},{"issue":"2","key":"10.1016\/j.humimm.2024.110797_b0200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"Statement on p-values: context, process, and purpose","volume":"70","author":"Lazar","year":"2016","journal-title":"Am. Stat."},{"issue":"2","key":"10.1016\/j.humimm.2024.110797_b0205","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1046\/j.0022-202x.2001.01656.x","article-title":"HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features","volume":"118","author":"Gudjonsson","year":"2002","journal-title":"J. Invest Dermatol"},{"issue":"9","key":"10.1016\/j.humimm.2024.110797_b0210","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/s41423-018-0089-9","article-title":"Failure of a T cell regulator: CD6 contributes to the aggravation of autoimmune inflammation","volume":"16","author":"Meyer","year":"2019","journal-title":"Cell Mol. Immunol"},{"key":"10.1016\/j.humimm.2024.110797_b0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133435","article-title":"Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: potential treatment targets","volume":"14","author":"Barbarroja","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.110797_b0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1016112","article-title":"Keratinocyte-induced ostimulation of human cells through CD6 - but not CD2 - activates mTOR and prevents oxidative stress","volume":"13","author":"Orlik","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.humimm.2024.110797_b0225","doi-asserted-by":"crossref","DOI":"10.4168\/aair.2019.11.5.677","article-title":"Activated leukocyte cell adhesion molecule modulates Th2 immune response in atopic dermatitis","volume":"11","author":"Oh","year":"2019","journal-title":"Allergy Asthma Immunol Res."},{"issue":"2","key":"10.1016\/j.humimm.2024.110797_b0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/09546634.2018.1437739","article-title":"Psoriasis in the perspective of predictive, preventive participatory and personalized medicine","volume":"29","author":"van de Kerkhof","year":"2018","journal-title":"J. Dermatolog Treat"},{"issue":"4","key":"10.1016\/j.humimm.2024.110797_b0235","doi-asserted-by":"crossref","first-page":"331","DOI":"10.5114\/ada.2018.77661","article-title":"Genetic polymorphism in psoriasis and its meaning for the treatment efficacy in the future","volume":"35","author":"Osmola-Mankowska","year":"2018","journal-title":"Postepy Dermatol Alergol"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:03:56Z","timestamp":1781568236000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0198885924000570"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110797","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymorphisms in the CD6-ALCAM axis may modulate psoriasis risk and outcomes","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.110797","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110797"}}